BioCentury
ARTICLE | Clinical News

Alogliptin/metformin regulatory update

December 5, 2011 8:00 AM UTC

Takeda submitted an NDA to FDA for alogliptin/metformin to treat Type II diabetes. The tablet is a combination of Takeda's alogliptin and metformin. Alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhib...